Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in Account PayablesOther Working Capital ChangesOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Change in Account Payables (2024 - 2025)

Zhengye Biotechnology Holding has reported Change in Account Payables over the past 2 years, most recently at $6.0 million for Q2 2025.

  • Quarterly Change in Account Payables changed N/A to $6.0 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $6.0 million through Jun 2025, changed N/A year-over-year, with the annual reading at -$478000.0 for FY2025, 753.57% down from the prior year.
  • Change in Account Payables was $6.0 million for Q2 2025 at Zhengye Biotechnology Holding, roughly flat from $6.0 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $6.0 million in Q4 2024 and troughed at $6.0 million in Q2 2025.